Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Vuk Zdinjak

1061 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Vext Science Revenue Declines 18% YoY, What About Adjusted EBITDA?

By Vuk Zdinjak
November 17, 9:23 AM
Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) revenue in the Q3 2022 was $7.7 million, a decrease of 18% compared to $9.4 million in Q3 2021, and a decrease of 12% compared to 8.8 million in Q2 2022.

CSE:VEXT

Read More
2 minute read
  • Earnings
  • News
  • Penny Stocks

Evogene Q3 Revenue Grows 208% YoY, Here Are The Details

By Vuk Zdinjak
November 17, 8:55 AM
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized per the collaboration agreement of Evogene's subsidiary AgPlen

EVGN

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Skye Initiates First-in-Human Phase 1 Clinical Trial For Cannabinoid Based Drug For Treatment Of Glaucoma

By Vuk Zdinjak
November 16, 12:28 PM
Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has initiated screening for its first-in-human Phase 1 trial of SBI-100 Ophthalmic Emulsion.

SKYE

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Lifeist Secures Equity Facility With Alumina Partners And Amends Stock Option Plan

By Vuk Zdinjak
November 16, 11:39 AM
Lifeist Wellness Inc.

NXTTF

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

TILT’s Jupiter Research To Bring Blend Pen By Aiden To The US And Canada

By Vuk Zdinjak
November 16, 11:15 AM
Jupiter Research, LLC, a subsidiary of TILT Holdings Inc. (OTCQX: TLLTF) (NEO:TILT) has entered into an agreement with House of Blends Inc. to distribute the Blend Pen by

TLLTF

Read More
1 minute read
  • Cannabis
  • Markets
  • News

Nextleaf Enters New Market Via Atlantic Cultivation

By Vuk Zdinjak
November 16, 10:45 AM
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA), a federally regulated manufacturer and distributor of cannabis extracts, announced its entry into the Newfoundland and Labrador market through a strategic partnership with Atlantic Cultivation Inc.

CSE:OILS

Read More
3 minute read
  • Cannabis
  • Earnings
  • Markets
  • News

CBDD Q3 Revenue Plummets, What About Net Loss?

By Vuk Zdinjak
November 16, 9:50 AM
Mellow Enterprise (OTCPK:CBDD) released Q3 results with revenue of $26,907 and gross profit of $6,303, this compares to Q3 2021 revenue of $6.4 million and gross loss of $432,336.

CBDD

Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

SNDL Renews Share Repurchase Program, SunStream Provides Additional Funding To SKYMINT

By Vuk Zdinjak
November 16, 9:05 AM
SNDL Inc. (NASDAQ: SNDL) announced that its board of directors has approved the renewal of the share repurchase program upon the expiry of

SNDL

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Rubicon Organics Hits Record Revenue Of $7.9M In Q3, What About Adjusted EBITDA?

By Vuk Zdinjak
November 15, 12:51 PM
Rubicon Organics Inc. (OTCQX: ROMJF) (TSXV:ROMJ) released its financial results for the third quarter ended September 30, 2022, revealing record net revenue of CA$10.5 million ($7.9 million), a 49% increase compared to CA$7 million in Q3 2021, and a 19% incr

ROMJF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Charlotte’s Web Stock Slightly Up On Secured $56.8M Investment From BAT

By Vuk Zdinjak
November 15, 12:04 PM
Charlotte's Web Holdings, Inc. (OTCQX: CWBHF) (TSX:CWEB) announced a $56.8 million investment from a subsidiary of BAT (NYSE: BTI) (LSE:BATS), which provides the company with incremental capital to fund growth initiati

BTI

Posts pagination

Previous 1 … 76 77 78 … 107 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service